Cargando…
Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean–Congo Hemorrhagic Fever Virus Nucleoprotein
Crimean–Congo hemorrhagic fever virus (CCHFV) infrequently causes hemorrhagic fever in humans with a case fatality rate of 30%. Currently, there is neither an internationally approved antiviral drug nor a vaccine against the virus. A replicon based on the Sindbis virus vector encoding the complete o...
Autores principales: | Tipih, Thomas, Heise, Mark, Burt, Felicity Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703447/ https://www.ncbi.nlm.nih.gov/pubmed/34960237 http://dx.doi.org/10.3390/vaccines9121491 |
Ejemplares similares
-
Crimean–Congo Hemorrhagic Fever Virus: Advances in Vaccine Development
por: Tipih, Thomas, et al.
Publicado: (2020) -
Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein
por: Lombe, Boniface Pongombo, et al.
Publicado: (2022) -
Persistence of Crimean-Congo Hemorrhagic Fever Virus RNA
por: Mathengtheng, Leholonolo, et al.
Publicado: (2020) -
Purification of Crimean–Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis
por: Lombe, Boniface Pongombo, et al.
Publicado: (2021) -
The DEVD motif of Crimean-Congo hemorrhagic fever virus nucleoprotein is essential for viral replication in tick cells
por: Salata, Cristiano, et al.
Publicado: (2018)